Trials / Sponsors / Anna Raciborska
Anna Raciborska
Academic / Other · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) Ewing Sarcoma | Phase 2 | 2023-10-24 |
| Recruiting | Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging Histiocytosis | Phase 3 | 2021-04-01 |
| Recruiting | Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients Histiocytosis | Phase 2 | 2021-04-01 |
| Recruiting | Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory Histiocy Histiocytosis | Phase 2 | 2021-04-01 |